Skip to main content
Clinical Trials/ACTRN12622000345785
ACTRN12622000345785
Not Yet Recruiting
N/A

Feasibility and Efficacy of a Multidisciplinary Therapy Coaching Program For Individuals With Premanifest and Manifest Huntington's Disease

Perpetual Limited0 sites84 target enrollmentFebruary 25, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Huntington's Disease
Sponsor
Perpetual Limited
Enrollment
84
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 25, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Perpetual Limited

Eligibility Criteria

Inclusion Criteria

  • Forty\-two individuals with premanifest HD (CAG \> 39, DBS \> 250, UHDRS\-TMS \< 5\) and 42 individuals with early manifest HD (CAG \> 39, UHDRS\-TMS \> 5, TFC \> 7\) will be recruited for this trial (effect size: f \= .25, a \= .05 and power (1\- ß) \= 80%). Participants will be required to provide written and informed consent prior to undertaking any study procedures.

Exclusion Criteria

  • Exclusion criteria for participants will include concomitant cardiovascular, metabolic, immunological, neurological and musculoskeletal conditions as well as recent or ongoing substance abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials